Kornitzer Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Kornitzer Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-365,393	Closed	-$2.15M	–	530
2025 Q2	$2.15M	Hold	365,393	–	–	0.04%	315
2025 Q1	$3.07M	Sell	365,393 -161,525	-31%	-$1.45M	0.06%	267
2024 Q4	$3.92M	Hold	526,918	–	–	0.08%	260
2024 Q3	$3.06M	Hold	526,918	–	–	0.06%	280
2024 Q2	$3.5M	Sell	526,918 -150,815	-22%	-$1.22M	0.07%	275
2024 Q1	$8.84M	Hold	677,733	–	–	0.16%	187
2023 Q4	$8.64M	Hold	677,733	–	–	0.17%	199
2023 Q3	$8.89M	Buy	677,733 +43,510	+7%	+$796K	0.18%	179
2023 Q2	$16.2M	Hold	634,223	–	–	0.32%	86
2023 Q1	$16M	Buy	634,223 +140,000	+28%	+$3.29M	0.32%	90
2022 Q4	$11.4M	Hold	494,223	–	–	0.23%	133
2022 Q3	$10.9M	Buy	494,223 +203,260	+70%	+$3.93M	0.23%	141
2022 Q2	$4.17M	Buy	+290,963	New	+$4.9M	0.08%	263

Other funds holding TMCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kornitzer Capital Management's TMCI Position: Q3 2025 in Review

Kornitzer Capital Management sold out of Treace Medical Concepts (TMCI) in Q3 2025, closing a stake of 365,393 shares — an estimated $2.15M sold.

Kornitzer Capital Management first reported a position in TMCI in Q2 2022 and held it in 13 quarters. The position peaked at $16.2M in Q2 2023. 119 funds tracked by Wall St. Rank hold TMCI as of Q3 2025.

Kornitzer Capital Management reported no remaining Treace Medical Concepts position as of Q3 2025 after selling out during the quarter.
Kornitzer Capital Management sold 365,393 Treace Medical Concepts shares in Q3 2025, an estimated $2.15M.
Kornitzer Capital Management first reported a position in Treace Medical Concepts in Q2 2022 and held it in 13 quarters.
Kornitzer Capital Management's Treace Medical Concepts position peaked at $16.2M in Q2 2023.
119 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2025.

Based on Kornitzer Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.